-
2
-
-
0024396459
-
Drugs from emasculated hormones: the principle of syntopic antagonism
-
J. Black Drugs from emasculated hormones: the principle of syntopic antagonism Science 245 1989 486 493
-
(1989)
Science
, vol.245
, pp. 486-493
-
-
Black, J.1
-
4
-
-
84906303552
-
An overview of FDA-approved new molecular entities: 1827-2013
-
M.S. Kinch An overview of FDA-approved new molecular entities: 1827-2013 Drug Discov. Today 19 2014 1033 1039
-
(2014)
Drug Discov. Today
, vol.19
, pp. 1033-1039
-
-
Kinch, M.S.1
-
5
-
-
77955578752
-
Beta blockers in hypertension
-
author reply 415-416
-
J.M. Cruickshank Beta blockers in hypertension Lancet 376 2010 415 author reply 415-416.
-
(2010)
Lancet
, vol.376
, pp. 415
-
-
Cruickshank, J.M.1
-
6
-
-
84910654115
-
Trends in pharmaceutical targeting of clinical indications: 1930-2013
-
M.S. Kinch Trends in pharmaceutical targeting of clinical indications: 1930-2013 Drug Discov. Today 2014 doi: 10.1016/j.drudis.2014.05.021
-
(2014)
Drug Discov. Today
-
-
Kinch, M.S.1
-
7
-
-
0020370796
-
Calcium entry blockers: uses and implications for anesthesiologists
-
J.G. Reves Calcium entry blockers: uses and implications for anesthesiologists Anesthesiology 57 1982 504 518
-
(1982)
Anesthesiology
, vol.57
, pp. 504-518
-
-
Reves, J.G.1
-
8
-
-
0016646573
-
Possible involvement of GABA in the central actions of benzodiazepines
-
W. Haefely Possible involvement of GABA in the central actions of benzodiazepines Adv. Biochem. Psychopharmacol. 14 1975 131 151
-
(1975)
Adv. Biochem. Psychopharmacol.
, vol.14
, pp. 131-151
-
-
Haefely, W.1
-
9
-
-
0016904516
-
Insights into protein biosynthesis and ribosome function through inhibitors
-
S. Pestka Insights into protein biosynthesis and ribosome function through inhibitors Prog. Nucleic Acid Res. Mol. Biol. 17 1976 217 245
-
(1976)
Prog. Nucleic Acid Res. Mol. Biol.
, vol.17
, pp. 217-245
-
-
Pestka, S.1
-
10
-
-
84907815937
-
An analysis of FDA-approved drugs for infectious disease: antibacterial agents
-
M.S. Kinch An analysis of FDA-approved drugs for infectious disease: antibacterial agents Drug Discov. Today 19 2014 1283 1287
-
(2014)
Drug Discov. Today
, vol.19
, pp. 1283-1287
-
-
Kinch, M.S.1
-
11
-
-
84885102013
-
Approval and withdrawal of new antibiotics and other antiinfectives in the US, 1980-2009
-
K. Outterson Approval and withdrawal of new antibiotics and other antiinfectives in the US, 1980-2009 J. Law Med. Ethics 41 2013 688 696
-
(2013)
J. Law Med. Ethics
, vol.41
, pp. 688-696
-
-
Outterson, K.1
-
12
-
-
84919395951
-
An analysis of FDA-approved drugs for oncology
-
M.S. Kinch An analysis of FDA-approved drugs for oncology Drug Discov. Today 2014 doi: 10.1016/j.drudis.2014.08.007
-
(2014)
Drug Discov. Today
-
-
Kinch, M.S.1
-
13
-
-
0025618812
-
From cloning to a commercial realization: human alpha interferon
-
E. Baron, and S. Narula From cloning to a commercial realization: human alpha interferon Crit. Rev. Biotechnol. 10 1990 179 190
-
(1990)
Crit. Rev. Biotechnol.
, vol.10
, pp. 179-190
-
-
Baron, E.1
Narula, S.2
-
15
-
-
0017128012
-
Converting enzyme inhibition and blood pressure regulation
-
A.C. Barger Converting enzyme inhibition and blood pressure regulation Agents Actions 6 1976 538 542
-
(1976)
Agents Actions
, vol.6
, pp. 538-542
-
-
Barger, A.C.1
-
16
-
-
0025552182
-
HIV-1 protease as a potential target for anti-AIDS therapy
-
T.D. Meek, and G.B. Dreyer HIV-1 protease as a potential target for anti-AIDS therapy Ann. N. Y. Acad. Sci. 616 1990 41 53
-
(1990)
Ann. N. Y. Acad. Sci.
, vol.616
, pp. 41-53
-
-
Meek, T.D.1
Dreyer, G.B.2
-
17
-
-
0001650127
-
Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A
-
S. Seelmeier Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A Proc. Natl. Acad. Sci. U. S. A. 85 1988 6612 6616
-
(1988)
Proc. Natl. Acad. Sci. U. S. A.
, vol.85
, pp. 6612-6616
-
-
Seelmeier, S.1
-
18
-
-
77956369648
-
Drug development for cancer chemoprevention: focus on molecular targets
-
K.A. Johnson, and P.H. Brown Drug development for cancer chemoprevention: focus on molecular targets Semin. Oncol. 37 2010 345 358
-
(2010)
Semin. Oncol.
, vol.37
, pp. 345-358
-
-
Johnson, K.A.1
Brown, P.H.2
-
19
-
-
84887893900
-
Neoclassic drug discovery: the case for lead generation using phenotypic and functional approaches
-
J.A. Lee, and E.L. Berg Neoclassic drug discovery: the case for lead generation using phenotypic and functional approaches J. Biomol. Screen. 18 2013 1143 1155
-
(2013)
J. Biomol. Screen.
, vol.18
, pp. 1143-1155
-
-
Lee, J.A.1
Berg, E.L.2
-
20
-
-
84875448716
-
Phenotypic vs. target-based drug discovery for first-in-class medicines
-
D.C. Swinney Phenotypic vs. target-based drug discovery for first-in-class medicines Clin. Pharmacol. Ther. 93 2013 299 301
-
(2013)
Clin. Pharmacol. Ther.
, vol.93
, pp. 299-301
-
-
Swinney, D.C.1
-
22
-
-
77952552641
-
Cheminformatics approaches to analyze diversity in compound screening libraries
-
L.B. Akella, and D. DeCaprio Cheminformatics approaches to analyze diversity in compound screening libraries Curr. Opin. Chem. Biol. 14 2010 325 330
-
(2010)
Curr. Opin. Chem. Biol.
, vol.14
, pp. 325-330
-
-
Akella, L.B.1
Decaprio, D.2
-
23
-
-
67650299761
-
Quantifying biogenic bias in screening libraries
-
J. Hert Quantifying biogenic bias in screening libraries Nat. Chem. Biol. 5 2009 479 483
-
(2009)
Nat. Chem. Biol.
, vol.5
, pp. 479-483
-
-
Hert, J.1
-
24
-
-
33747754105
-
Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse
-
T.K. Bjarnadottir Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse Genomics 88 2006 263 273
-
(2006)
Genomics
, vol.88
, pp. 263-273
-
-
Bjarnadottir, T.K.1
-
26
-
-
70350038016
-
Mapping the human membrane proteome: a majority of the human membrane proteins can be classified according to function and evolutionary origin
-
M.S. Almén Mapping the human membrane proteome: a majority of the human membrane proteins can be classified according to function and evolutionary origin BMC Biol. 7 2009 50
-
(2009)
BMC Biol.
, vol.7
, pp. 50
-
-
Almén, M.S.1
-
27
-
-
0035479253
-
How many nuclear hormone receptors are there in the human genome?
-
M. Robinson-Rechavi How many nuclear hormone receptors are there in the human genome? Trends Genet. 17 2001 554 556
-
(2001)
Trends Genet.
, vol.17
, pp. 554-556
-
-
Robinson-Rechavi, M.1
-
28
-
-
79957957725
-
Strategies in the rational drug design
-
T. Mavromoustakos Strategies in the rational drug design Curr. Med. Chem. 18 2011 2517 2530
-
(2011)
Curr. Med. Chem.
, vol.18
, pp. 2517-2530
-
-
Mavromoustakos, T.1
|